Literature DB >> 106432

Effects of atenolol and propranolol on human performance and subjective feelings.

A A Landauer, D A Pocock, F W Prott.   

Abstract

In a double-blind, double crossover experiment, 18 healthy young men received over 3-day periods either 100 mg atenolol, 80 mg propranolol, or placebo. The subjects underwent various motor and cognitive tests 18 h after each last dose had been taken. Propranolol significantly increased variability of a choice reaction-time task. Scores on various subjective rating scales showed that propranolol had a larger mood elevating effect than atenolol. Heart rate and blood pressure were significantly reduced 24h after atenolol medication; these effects were absent or reduced after propranolol had been given.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106432     DOI: 10.1007/bf00432296

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Measurement of activation through self-report.

Authors:  R E Thayer
Journal:  Psychol Rep       Date:  1967-04

2.  Propranolol and skilled human performance.

Authors:  A A Landauer; L B Jellett; J Kirk
Journal:  Pharmacol Biochem Behav       Date:  1976-03       Impact factor: 3.533

3.  The effects of atenolol (tenormin) and methyldopa on simple tests of central nervous function.

Authors:  P F Bayliss; S M Duncan
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

4.  The psychomotor effects of atenolol and other antihypertensive agents.

Authors:  A B Clayton; P G Harvey; T A Betts
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

5.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

Review 6.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 7.  Use of beta-adrenergic receptor blocking drugs in psychiatry.

Authors:  F A Whitlock; J Price
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Controlled study of atenolol in treatment of hypertension.

Authors:  L Hansson; H Aberg; B E Karlberg; A Westerlund
Journal:  Br Med J       Date:  1975-05-17

9.  Once-daily dosing with Atenolol in patients with mild or moderate hypertension.

Authors:  A P Douglas-Jones; J M Cruickshank
Journal:  Br Med J       Date:  1976-04-24

10.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

View more
  13 in total

1.  Single dose pharmacokinetics and pharmacodynamics of oral oxazepam during concomitant administration of propranolol and labetalol.

Authors:  J Sonne; M Døssing; S Loft; K L Olesen; A Vollmer-Larsen; M A Victor; O Hamberg; H Thyssen
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

2.  Anxiolytic effects of acebutolol and atenolol in healthy volunteers with induced anxiety.

Authors:  S G Kilminster; M J Lewis; D M Jones
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

4.  CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.

Authors:  E Dimenäs; C Dahlöf; B Olofsson; I Wiklund
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

5.  Cognitive function in hypertensives treated with atenolol or propranolol.

Authors:  D M Palac; R D Cornish; W J McDonald; D A Middaugh; D Howieson; S P Bagby
Journal:  J Gen Intern Med       Date:  1990 Jul-Aug       Impact factor: 5.128

6.  The relationship between serum concentrations and central nervous system actions of metoprolol.

Authors:  F M Gengo; J C Ermer; C Carey; G C Kalonaros; W B McHugh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-02       Impact factor: 10.154

7.  Beta-blockers and psychometric performance: studies in normal volunteers.

Authors:  D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists.

Authors:  Britta Hahn; Ian P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2004-07-14       Impact factor: 4.530

9.  Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.

Authors:  Vassilis Koudas; Alexandra Nikolaou; Eugenia Hourdaki; Stella G Giakoumaki; Panos Roussos; Panos Bitsios
Journal:  Psychopharmacology (Berl)       Date:  2009-03-14       Impact factor: 4.530

10.  Central effects of single oral doses of propranolol in man.

Authors:  S A Salem; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.